Trilogy International Partners Inc (TSE:TRL) had its target price dropped by stock analysts at Scotiabank from C$12.50 to C$11.00 in a research report issued to clients and investors on Thursday. The brokerage presently has an “outperform” rating on the specialty pharmaceutical company’s stock. Scotiabank’s price objective suggests a potential upside of 40.75% from the company’s previous close.
Separately, TD Securities upgraded Trilogy International Partners from a “hold” rating to a “buy” rating and set a C$11.50 target price on the stock in a report on Thursday, July 6th.
Trilogy International Partners (TSE:TRL) opened at 7.815 on Thursday. The company’s market cap is $332.24 million. The stock has a 50 day moving average price of $8.34 and a 200-day moving average price of $9.33. Trilogy International Partners has a 12-month low of $7.54 and a 12-month high of $10.48.
About Trilogy International Partners
Trilogy International Partners Inc, formerly Alignvest Acquisition Corporation, is a Canada-based wireless telecommunications operator. The Company provides wireless communications services through its subsidiaries in New Zealand and Bolivia. Its subsidiaries include Viva and 2degrees. Viva provides voice and a range of data services to its mobile customers over its third generation (3G)-enabled global system for mobile communications (GSM) and fourth generation (4G) long term evolution (LTE) networks.
What are top analysts saying about Trilogy International Partners Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Trilogy International Partners Inc and related companies.